226 related articles for article (PubMed ID: 19781367)
21. When to suspect and how to diagnose pulmonary lymphangioleiomyomatosis.
Naalsund A; Johansen B; Foerster A; Kolbenstvedt A
Respirology; 1996 Sep; 1(3):207-12. PubMed ID: 9424398
[TBL] [Abstract][Full Text] [Related]
22. Lymphangioleiomyomatosis in patients with tuberous sclerosis: a national centre audit.
Johnson J; Somerfield W; Johnson SR
Orphanet J Rare Dis; 2024 Mar; 19(1):137. PubMed ID: 38532450
[TBL] [Abstract][Full Text] [Related]
23. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.
Ferrans VJ; Yu ZX; Nelson WK; Valencia JC; Tatsuguchi A; Avila NA; Riemenschn W; Matsui K; Travis WD; Moss J
J Nippon Med Sch; 2000 Oct; 67(5):311-29. PubMed ID: 11031360
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary lymphangiomyomatosis. A review.
Corrin B; Liebow AA; Friedman PJ
Am J Pathol; 1975 May; 79(2):348-82. PubMed ID: 1146965
[TBL] [Abstract][Full Text] [Related]
25. Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis.
Zhe X; Schuger L
J Histochem Cytochem; 2004 Dec; 52(12):1537-42. PubMed ID: 15557209
[TBL] [Abstract][Full Text] [Related]
26. Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis.
Inoue Y; King TE; Barker E; Daniloff E; Newman LS
Am J Respir Crit Care Med; 2002 Sep; 166(5):765-73. PubMed ID: 12204879
[TBL] [Abstract][Full Text] [Related]
27. [Lymphangioleiomyomatosis].
Clementsen PS; Folke K; Faurschou P
Ugeskr Laeger; 1995 Jan; 157(3):298-9. PubMed ID: 7846779
[TBL] [Abstract][Full Text] [Related]
28. Lymphangioleiomyomatosis: pulmonary and abdominal findings with pathologic correlation.
Pallisa E; Sanz P; Roman A; Majó J; Andreu J; Cáceres J
Radiographics; 2002 Oct; 22 Spec No():S185-98. PubMed ID: 12376610
[TBL] [Abstract][Full Text] [Related]
29. Expression of human telomerase reverse transcriptase in lymphangioleiomyomatosis.
Kumaki F; Takeda K; Yu ZX; Moss J; Ferrans VJ
Am J Respir Crit Care Med; 2002 Jul; 166(2):187-91. PubMed ID: 12119231
[TBL] [Abstract][Full Text] [Related]
30. Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases.
Matsui K; Tatsuguchi A; Valencia J; Yu Zx; Bechtle J; Beasley MB; Avila N; Travis WD; Moss J; Ferrans VJ
Hum Pathol; 2000 Oct; 31(10):1242-8. PubMed ID: 11070117
[TBL] [Abstract][Full Text] [Related]
31. Chylothorax in lymphangioleiomyomatosis.
Ryu JH; Doerr CH; Fisher SD; Olson EJ; Sahn SA
Chest; 2003 Feb; 123(2):623-7. PubMed ID: 12576391
[TBL] [Abstract][Full Text] [Related]
32. Lymphangioleiomyomatosis.
Kelly J; Moss J
Am J Med Sci; 2001 Jan; 321(1):17-25. PubMed ID: 11202475
[TBL] [Abstract][Full Text] [Related]
33. Lymphangioleiomyomatosis initially presenting with abdominal pain: a case report.
Lu HC; Wang J; Tsang YM; Lin MC; Li YW
Clin Imaging; 2003; 27(3):166-70. PubMed ID: 12727053
[TBL] [Abstract][Full Text] [Related]
34. Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis.
Kumasaka T; Seyama K; Mitani K; Sato T; Souma S; Kondo T; Hayashi S; Minami M; Uekusa T; Fukuchi Y; Suda K
Am J Surg Pathol; 2004 Aug; 28(8):1007-16. PubMed ID: 15252306
[TBL] [Abstract][Full Text] [Related]
35. The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma.
Johnson SR; Clelland CA; Ronan J; Tattersfield AE; Knox AJ
Histopathology; 2002 May; 40(5):458-63. PubMed ID: 12010366
[TBL] [Abstract][Full Text] [Related]
36. Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis.
Taveira-DaSilva AM; Hedin C; Stylianou MP; Travis WD; Matsui K; Ferrans VJ; Moss J
Am J Respir Crit Care Med; 2001 Sep; 164(6):1072-6. PubMed ID: 11587999
[TBL] [Abstract][Full Text] [Related]
37. High levels of exhaled nitric oxide (NO) and NO synthase III expression in lesional smooth muscle in lymphangioleiomyomatosis.
Dweik RA; Laskowski D; Ozkan M; Farver C; Erzurum SC
Am J Respir Cell Mol Biol; 2001 Apr; 24(4):414-8. PubMed ID: 11306434
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex.
Moss J; Avila NA; Barnes PM; Litzenberger RA; Bechtle J; Brooks PG; Hedin CJ; Hunsberger S; Kristof AS
Am J Respir Crit Care Med; 2001 Aug; 164(4):669-71. PubMed ID: 11520735
[TBL] [Abstract][Full Text] [Related]
39. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.
Young LR; Vandyke R; Gulleman PM; Inoue Y; Brown KK; Schmidt LS; Linehan WM; Hajjar F; Kinder BW; Trapnell BC; Bissler JJ; Franz DN; McCormack FX
Chest; 2010 Sep; 138(3):674-81. PubMed ID: 20382711
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary lymphangiomyomatosis diagnosed by effusion cytology. A case report.
Itami M; Teshima S; Asakuma Y; Chino H; Aoyama K; Fukushima N
Acta Cytol; 1997; 41(2):522-8. PubMed ID: 9100792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
